Company: MYSEW
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-110045
Chunk: 172

Company: Myseum, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 172
---
, 2025 and 2024, after adjusting net loss for the net loss of subsidiary attributable to noncontrolling interest of $316,235 and $556,513,
respectively, net loss attributable to common shareholders of was $3,891,545, or ($0.93) per common share (basic and diluted) and $3,392,860,
or ($1.15) per common share (basic and diluted), respectively, an increase of $498,685, or 14.7%.

Liquidity, Capital Resources and Plan of Operations 

The accompanying unaudited consolidated financial
statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities and
commitments in the ordinary course of business. As of September 30, 2025, we had cash and cash equivalents of $457,626, short-term investments
of $4,346,310, and working capital of $4,193,316. Short-term investments include U.S. Treasury zero coupon bills that are all highly rated
and have initial maturities between two and eight months. On January 8, 2025, the Company entered into a securities purchase agreement
(the “Purchase Agreement”) with certain institutional investors pursuant to which the Company agreed to sell to such investors
1,200,000 shares of common stock of the Company at a purchase price of $4.25 per share of Common Stock (the “Offering”). The
closing of the sales of these securities under the Purchase Agreement took place on January 9, 2025 and we received net proceeds of $4,532,000.
Net cash used in operations was $3,515,434 for the nine months ended September 30, 2025. Until such time that the Company implements its
growth strategy, it expects to continue to generate operating losses in the foreseeable future, mostly due to corporate overhead, research
and development, and costs of being a public company. We believe that our existing working capital and cash on hand will provide sufficient
cash to enable the Company to meet its operating needs and debt requirements for the next twelve months from the issuance date of this
report. 

Our primary uses of cash have been for research
and development, compensation and related expenses, fees paid to third parties for professional services, marketing and advertising expenses,
and general and administrative expenses. All funds received have been expended in the furtherance of growing the business. We received
funds from the sale